Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression

NCT05378347 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT05378347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression
Lead sponsor
Medtronic Cardiovascular
Phase
Not applicable
Overall status
Recruiting
Start date
January 5, 2023
Completion date
May 31, 2031
Enrollment
600 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm, abdominal aortic aneurysm >= 5.0 centimeters in female (disorder), abdominal aortic aneurysm >= 5.5 centimeters in male (disorder)